|
Volumn 1, Issue 2, 2012, Pages 145-163
|
PDK1 inhibitors
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE;
ANTINEOPLASTIC AGENT;
PDPK1 PROTEIN, HUMAN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE INHIBITOR;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DRUG DESIGN;
HUMAN;
METABOLISM;
NEOPLASMS;
PATENT;
PATHOLOGY;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DESIGN;
HUMANS;
NEOPLASMS;
PATENTS AS TOPIC;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTEIN KINASE INHIBITORS;
SIGNAL TRANSDUCTION;
|
EID: 84876222208
PISSN: None
EISSN: 20468962
Source Type: Journal
DOI: 10.4155/ppa.12.17 Document Type: Review |
Times cited : (22)
|
References (0)
|